Cost-effectiveness of precision medicine: a scoping review | SpringerLinkAs healthcare costs rise in the United States, debate is ongoing over how to obtain better value for dollars spent. In this context, the use of cost-effectiveness analysis CEA is more compelling than ever. The revisions draw on advances in the field and include three new chapters that capture research on decision modeling, methods for evidence synthesis, and ethical considerations. Keywords: Cost-effectiveness analysis , reference case , healthcare perspective , societal perspective , Impact Inventory , recommendations. Peter J.
Economic Evaluation Webcast Part 4 of 5: Benefit-Cost Analysis
Cost-effectiveness of precision medicine: a scoping review
Sculpher Joanna E. Health Technol Assess - Vegter S, Postma MJ et al Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature. Work and pain Elaine Wainwright and Christopher Eccleston.
Akhmetov I, Bubnov RV Assessing value of innovative molecular diagnostic tests in the concept of predicti. Methods for the economic evaluation of health programmes. Cost-effectiveness analysis in health a practical approach. Reflecting Uncertainty in Cost-Effectiveness Analysis ?
Precision medicine PM aims to improve patient outcomes by stratifying or individualizing diagnosis and treatment decisions. Previous reviews found inconclusive evidence as to the cost-effectiveness of PM. The purpose of this scoping review was to describe current research findings on the cost-effectiveness of PM and to identify characteristics of cost-effective interventions. We searched PubMed with a combination of terms related to PM and economic evaluations and included studies published between and A total of 83 articles were included, of which two-thirds were published in Europe and the USA.
Owens, Joanna E. Destroying Sanctuary Sandra L. In : Guinness L, editors. You JH Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Further, in our initial literature se?